Adicet Bio, Inc.

Adicet Bio, Inc. disclosed substantial doubt about its ability to continue as a going concern

No substantial-doubt conclusion identified → Substantial doubt about ability to continue as a going concern

… product candidates in certain territories or indications that we would prefer to develop and commercialize ourselves. The Company expects that its current cash and cash equivalents and short-term investments may not be sufficient to fund operations for at least twelve months from the date of issuance of these unaudited consolidated financial statements. Accordingly, the Company has concluded that substantial doubt exists about the Company’s ability to continue as a going concern. The accompanying financial statements have been prepared on a going concern basis, which contemplates the…

Source filing ↗ Prior filing ↗

Adicet Bio, Inc. reported internal control effective again after a material weakness

Material weakness in internal control → Internal control reported effective

The weakness was first reported on 2025-03-06 — 440 days and 2 annual reports before this one.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, assessed our internal control over financial reporting as of December 31, 2025. Management based its assessment on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and concluded that our internal control over financial reporting was effective at the reasonable assurance level as of December 31, 2025. This Annual Report on Form…

Source filing ↗ Prior filing ↗